We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$111M
1-Year Est. Return
74.4%
This Fund
S&P 500
This Quarter
Est. Return
-14.56%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$688M
AUM Growth
-$52M
(-7%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-26.07%
Top 10 Holdings %
Top 10 Hldgs %
65.57%
Holding
231
New
46
Increased
68
Reduced
48
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIOS
AIOS Tech
AIOS
|
+$28.5M |
| 2 |
AGM Group Holdings
AGMH
|
+$13.2M |
| 3 |
OG
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
|
+$7.66M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$7.53M |
| 5 |
Context Therapeutics
CNTX
|
+$6.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZNB
Zeta Network Group
ZNB
|
+$3.39M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$3.33M |
| 3 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
+$3.06M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$2.84M |
| 5 |
Flux Power
FLUX
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 74.53% |
| 2 | Healthcare | 8.91% |
| 3 | Financials | 5.9% |
| 4 | Technology | 5.82% |
| 5 | Consumer Discretionary | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCLI
51
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $2.07M | 0.3% |
345
+16
| +5% | +$788 |
|
|
BCLI
52
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $2.05M | 0.3% |
34,214
+2,459
| +8% | +$121K |
|
53
PUT
Atossa Therapeutics
ATOS
$25M
| $1.98M | 0.29% |
825
-223
| -21% | -$8.16K |
|
|
KNDI
54
PUT
Kandi Technologies Group
KNDI
$60.9M
| $1.93M | 0.28% |
6,021
-3,721
| -38% | -$15.2K |
|
55
ProShares Bitcoin Strategy ETF
BITO
$1.67B
| $1.91M | 0.28% |
+66,000
| New | +$2.38M |
|
56
Marathon Digital Holdings
MARA
$4.44B
| $1.91M | 0.28% |
58,049
-14,594
| -20% | -$698K |
|
57
Alset
AEI
$39.3M
| $1.84M | 0.27% |
+164,516
| New | +$4.88M |
|
|
BIOR
58
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $1.61M | 0.23% |
31
+11
| +55% | +$7.89K |
|
59
Pulmatrix
PULM
$5.15M
| $1.58M | 0.23% |
+180,852
| New | +$2.47M |
|
|
AMRN
60
PUT
Amarin Corp
AMRN
$291M
| $1.54M | 0.22% |
228
+22
| +11% | +$1.82K |
|
61
Globus Maritime Ltd
GLBS
$80.3M
| $1.5M | 0.22% |
716,376
+159,493
| +29% | +$425K |
|
62
Heartbeam
BEAT
$22.9M
| $1.49M | 0.22% |
+483,320
| New | +$1.83M |
|
|
HCDIZ
63
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
| $1.47M | 0.21% |
+1,910,774
| New | +$1.1M |
|
64
Lisata Therapeutics
LSTA
$14.7M
| $1.35M | 0.2% |
107,128
+43,512
| +68% | +$672K |
|
65
CALL
Curis
CRIS
$2.72M
| $1.33M | 0.19% |
7
+4
| +133% | +$9.51K |
|
|
CHRN
66
ChronoScale Holdings
CHRN
$2.77B
| $1.32M | 0.19% |
33,249
+5,237
| +19% | +$286K |
|
|
KNDI
67
Kandi Technologies Group
KNDI
$60.9M
| $1.3M | 0.19% |
403,724
+66,294
| +20% | +$270K |
|
68
ReWalk Robotics
LFWD
$20.2M
| $1.27M | 0.18% |
12,288
-7,150
| -37% | -$815K |
|
|
CORZ
69
CALL
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $1.22M | 0.18% |
+1,114
| New | +$13.1K |
|
|
AMRN
70
Amarin Corp
AMRN
$291M
| $1.17M | 0.17% |
17,403
+9,964
| +134% | +$825K |
|
71
PUT
NRX Pharmaceuticals
NRXP
$151M
| $1.15M | 0.17% |
241
+148
| +159% | +$10.7K |
|
|
NBEV
72
CALL
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $1.15M | 0.17% |
11,132
+422
| +4% | +$557 |
|
73
OLB
OLB
$6.34M
| $1.11M | 0.16% |
+42,072
| New | +$1.92M |
|
|
SPI
74
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $1.08M | 0.16% |
2,988
-142
| -5% | -$681 |
|
|
75
Curis
CRIS
$2.72M
| $1.08M | 0.16% |
566
+315
| +125% | +$749K |
|
Similar funds
IWA
BFA
WPWM
BCM
ZS
KC
FI
CIM
Sabby Management's Q4 2021 Portfolio in Review
As of Q4 2021, Sabby Management held 231 positions worth $688M, down 7% from $740M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Sabby Management withdrew a net $179M in Q4 2021, closing 42 positions and reducing 48 holdings. Its most notable exit was Tricida, Inc. Common Stock, an estimated $3.06M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, down from 77% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Sabby Management opened a new position in AIOS Tech worth $10.4M.
- Sabby Management's largest Q4 2021 buy was AIOS Tech: 16,134 shares worth $10.4M.
- Sabby Management added most to Acutus Medical Inc in Q4 2021, an estimated $3.52M increase.
- Sabby Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.33M.
- Sabby Management fully exited Tricida, Inc. Common Stock in Q4 2021, selling an estimated $3.06M.
- Sabby Management's ten largest holdings make up 66% of its $688M portfolio in Q4 2021.
- Sabby Management opened 46 new positions and closed 42 in Q4 2021.
- Sabby Management's portfolio value fell 7% quarter-over-quarter to $688M.
Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.